A. Brogi et al., INTERACTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP120 WITH A GALACTOGLYCEROLIPID ASSOCIATED WITH HUMAN SPERM, AIDS research and human retroviruses, 12(6), 1996, pp. 483-489
The expression of a molecule recognized by anti-galactosyl ceramide an
tibodies (MAb) O1 on the surface membrane of human spermatozoa was inv
estigated by biochemical and immunochemical methods. Indirect immunofl
uorescence shows that this molecule is preferentially localized on the
middle piece of the sperm tail, Immune-thin-layer chromatography has
identified it as a glycolipid related but not identical to galactosylc
eramide. Consistent with a structure similar to galactosylceramide, th
e sperm glycolipid is capable of binding gp120. An improved ELISA has
been utilized to demonstrate the specificity of binding of the antibod
ies and gp120 to the isolated lipid fraction, Identity of the binding
site of the two ligands to the glycolipid is suggested by competition
assays. On the basis of preliminary biochemical analysis this glycolip
id was tentatively classified as a galactosylalkylacylglycerolipid (Ga
lAAG), the nonsulfated form of the seminolipid, a glycolipid known to
be present in the testis and germ cells of mammals. These data indicat
e that human sperm express a glycolipid similar in structure to the re
ceptor for HIV described on the CD4(-) neural and colonic epithelial c
ell Lines, and moreover suggest that this glycolipid could also functi
on as HIV receptor and possibly be implicated in its transmission.